This site is intended for healthcare professionals only
LoginRegister
Lupin and TB Alliance Join Forces to Advance TelacebecUSFDA issues EIR for Lupin Somerset facility
NPPA Expands I.V. Fluid Price List, Adds 5 Manufacturers and New PacksNPPA authority rejects Sun Pharmaceuticals application for separate ceiling price for Antibiotic...
Roche Drops Muscle Disease Drug After Trial FailureRoche gets USFDA nod for chronic blood disorder treatment Crovalimab
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentJnJ completes acquisition of Proteologix
Takeda announces closing of partnership with Innovent Biologics for oncology medicinesTakeda gets European Commission approval for Fruzaqla for previously treated metastatic Colorectal...
CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer IndicationsBristol Myers Squibb application for subcutaneous Nivolumab validated by EMA
Submit safety data of Rotavirus vaccine in 1 to 2 years age group: CDSCO panel Tells Bharat Biotech on Oral Rotavirus VaccineSubmit safety data of Rotavirus vaccine in 1 to 2 years age group: CDSCO panel Tells Bharat Biotech...
USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug SoaanzWHO, Eli Lilly warn against fake versions of popular weight loss, diabetes drugs
USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three ObservationsCipla Goa facility gets 6 USFDA observations
Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid TariffsJnJ seeks USFDA approval for Tremfya for moderately to severely active Crohn's disease
Sanofi India appoints Haresh Vala as Company Secretary, Compliance OfficerSanofi names Audrey Duval Derveloy as Executive Vice President, Global Head of Corporate Affairs
Bristol Myers Squibb gets USFDA accelerated approval for Krazati, Cetuximab combo for colorectal cancerBristol Myers Squibb gets USFDA accelerated approval for Krazati, Cetuximab combo for colorectal...
X